Report Detail
Global Diagnostic Radiopharmaceuticals Sales Market Report 2021
- RnM3260715 |
- 28 April, 2021 |
- Global |
- 143 Pages |
- QYResearch |
- Pharma & Healthcare
The global Diagnostic Radiopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Technetium 99
Fluorine 18
Other
Diagnostic radiopharmaceuticals are mainly divided into technetium 99, fluorine 18 and others. Among them, technetium 99 accounted for the main part, accounting for about 47.56% of the total market in 2019.
Segment by Application
Oncology
Cardiology
Other
Diagnostic radiopharmaceutical applications are mainly for oncology, cardiology and others. Among them, oncology accounts for the main part, accounting for about 45.8% of the total market in 2019.
The Diagnostic Radiopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Diagnostic Radiopharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
1 Diagnostic Radiopharmaceuticals Market Overview
- 1.1 Diagnostic Radiopharmaceuticals Product Scope
- 1.2 Diagnostic Radiopharmaceuticals Segment by Type
- 1.2.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Technetium 99
- 1.2.3 Fluorine 18
- 1.2.4 Other
- 1.3 Diagnostic Radiopharmaceuticals Segment by Application
- 1.3.1 Global Diagnostic Radiopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Oncology
- 1.3.3 Cardiology
- 1.3.4 Other
- 1.4 Diagnostic Radiopharmaceuticals Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Diagnostic Radiopharmaceuticals Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Diagnostic Radiopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Diagnostic Radiopharmaceuticals Price Trends (2016-2027)
2 Diagnostic Radiopharmaceuticals Estimates and Forecasts by Region
- 2.1 Global Diagnostic Radiopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
- 2.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
- 2.3 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Diagnostic Radiopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.2 Europe Diagnostic Radiopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.3 China Diagnostic Radiopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.4 Japan Diagnostic Radiopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Diagnostic Radiopharmaceuticals Estimates and Projections (2016-2027)
- 2.4.6 India Diagnostic Radiopharmaceuticals Estimates and Projections (2016-2027)
3 Global Diagnostic Radiopharmaceuticals Competition Landscape by Players
- 3.1 Global Top Diagnostic Radiopharmaceuticals Players by Sales (2016-2021)
- 3.2 Global Top Diagnostic Radiopharmaceuticals Players by Revenue (2016-2021)
- 3.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2020)
- 3.4 Global Diagnostic Radiopharmaceuticals Average Price by Company (2016-2021)
- 3.5 Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Diagnostic Radiopharmaceuticals Market Size by Type
- 4.1 Global Diagnostic Radiopharmaceuticals Historic Market Review by Type (2016-2021)
- 4.1.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
- 4.1.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Diagnostic Radiopharmaceuticals Price by Type (2016-2021)
- 4.2 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2022-2027)
- 4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2022-2027)
5 Global Diagnostic Radiopharmaceuticals Market Size by Application
- 5.1 Global Diagnostic Radiopharmaceuticals Historic Market Review by Application (2016-2021)
- 5.1.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
- 5.1.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Diagnostic Radiopharmaceuticals Price by Application (2016-2021)
- 5.2 Global Diagnostic Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2022-2027)
- 5.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Application (2022-2027)
6 North America Diagnostic Radiopharmaceuticals Market Facts & Figures
- 6.1 North America Diagnostic Radiopharmaceuticals Sales by Company
- 6.1.1 North America Diagnostic Radiopharmaceuticals Sales by Company (2016-2021)
- 6.1.2 North America Diagnostic Radiopharmaceuticals Revenue by Company (2016-2021)
- 6.2 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Type
- 6.2.1 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
- 6.3 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Application
- 6.3.1 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2022-2027)
7 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures
- 7.1 Europe Diagnostic Radiopharmaceuticals Sales by Company
- 7.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Company (2016-2021)
- 7.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Company (2016-2021)
- 7.2 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Type
- 7.2.1 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
- 7.3 Europe Diagnostic Radiopharmaceuticals Sales Breakdown by Application
- 7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Diagnostic Radiopharmaceuticals Market Facts & Figures
- 8.1 China Diagnostic Radiopharmaceuticals Sales by Company
- 8.1.1 China Diagnostic Radiopharmaceuticals Sales by Company (2016-2021)
- 8.1.2 China Diagnostic Radiopharmaceuticals Revenue by Company (2016-2021)
- 8.2 China Diagnostic Radiopharmaceuticals Sales Breakdown by Type
- 8.2.1 China Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
- 8.2.2 China Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
- 8.3 China Diagnostic Radiopharmaceuticals Sales Breakdown by Application
- 8.3.1 China 313 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Diagnostic Radiopharmaceuticals Market Facts & Figures
- 9.1 Japan Diagnostic Radiopharmaceuticals Sales by Company
- 9.1.1 Japan Diagnostic Radiopharmaceuticals Sales by Company (2016-2021)
- 9.1.2 Japan Diagnostic Radiopharmaceuticals Revenue by Company (2016-2021)
- 9.2 Japan Diagnostic Radiopharmaceuticals Sales Breakdown by Type
- 9.2.1 Japan Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
- 9.3 Japan Diagnostic Radiopharmaceuticals Sales Breakdown by Application
- 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Diagnostic Radiopharmaceuticals Market Facts & Figures
- 10.1 Southeast Asia Diagnostic Radiopharmaceuticals Sales by Company
- 10.1.1 Southeast Asia Diagnostic Radiopharmaceuticals Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Diagnostic Radiopharmaceuticals Revenue by Company (2016-2021)
- 10.2 Southeast Asia Diagnostic Radiopharmaceuticals Sales Breakdown by Type
- 10.2.1 Southeast Asia Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Diagnostic Radiopharmaceuticals Sales Breakdown by Application
- 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Diagnostic Radiopharmaceuticals Market Facts & Figures
- 11.1 India Diagnostic Radiopharmaceuticals Sales by Company
- 11.1.1 India Diagnostic Radiopharmaceuticals Sales by Company (2016-2021)
- 11.1.2 India Diagnostic Radiopharmaceuticals Revenue by Company (2016-2021)
- 11.2 India Diagnostic Radiopharmaceuticals Sales Breakdown by Type
- 11.2.1 India Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
- 11.2.2 India Diagnostic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
- 11.3 India Diagnostic Radiopharmaceuticals Sales Breakdown by Application
- 11.3.1 India Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
- 11.3.2 India Diagnostic Radiopharmaceuticals Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Diagnostic Radiopharmaceuticals Business
- 12.1 Cardinal Health
- 12.1.1 Cardinal Health Corporation Information
- 12.1.2 Cardinal Health Business Overview
- 12.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Products Offered
- 12.1.5 Cardinal Health Recent Development
- 12.2 GE Healthcare
- 12.2.1 GE Healthcare Corporation Information
- 12.2.2 GE Healthcare Business Overview
- 12.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Products Offered
- 12.2.5 GE Healthcare Recent Development
- 12.3 Curium Pharma
- 12.3.1 Curium Pharma Corporation Information
- 12.3.2 Curium Pharma Business Overview
- 12.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Products Offered
- 12.3.5 Curium Pharma Recent Development
- 12.4 Jubilant Pharma
- 12.4.1 Jubilant Pharma Corporation Information
- 12.4.2 Jubilant Pharma Business Overview
- 12.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Products Offered
- 12.4.5 Jubilant Pharma Recent Development
- 12.5 Bracco Imaging
- 12.5.1 Bracco Imaging Corporation Information
- 12.5.2 Bracco Imaging Business Overview
- 12.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Products Offered
- 12.5.5 Bracco Imaging Recent Development
- 12.6 Advanced Accelerator Applications
- 12.6.1 Advanced Accelerator Applications Corporation Information
- 12.6.2 Advanced Accelerator Applications Business Overview
- 12.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Products Offered
- 12.6.5 Advanced Accelerator Applications Recent Development
- 12.7 SIEMENS
- 12.7.1 SIEMENS Corporation Information
- 12.7.2 SIEMENS Business Overview
- 12.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 SIEMENS Diagnostic Radiopharmaceuticals Products Offered
- 12.7.5 SIEMENS Recent Development
- 12.8 China Isotope & Radiation
- 12.8.1 China Isotope & Radiation Corporation Information
- 12.8.2 China Isotope & Radiation Business Overview
- 12.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Products Offered
- 12.8.5 China Isotope & Radiation Recent Development
- 12.9 Dongcheng Pharmaceutical Group
- 12.9.1 Dongcheng Pharmaceutical Group Corporation Information
- 12.9.2 Dongcheng Pharmaceutical Group Business Overview
- 12.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Products Offered
- 12.9.5 Dongcheng Pharmaceutical Group Recent Development
- 12.10 Lantheus
- 12.10.1 Lantheus Corporation Information
- 12.10.2 Lantheus Business Overview
- 12.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Lantheus Diagnostic Radiopharmaceuticals Products Offered
- 12.10.5 Lantheus Recent Development
- 12.11 Eli Lilly
- 12.11.1 Eli Lilly Corporation Information
- 12.11.2 Eli Lilly Business Overview
- 12.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Products Offered
- 12.11.5 Eli Lilly Recent Development
13 Diagnostic Radiopharmaceuticals Manufacturing Cost Analysis
- 13.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
- 13.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Diagnostic Radiopharmaceuticals Distributors List
- 14.3 Diagnostic Radiopharmaceuticals Customers
15 Market Dynamics
- 15.1 Diagnostic Radiopharmaceuticals Market Trends
- 15.2 Diagnostic Radiopharmaceuticals Drivers
- 15.3 Diagnostic Radiopharmaceuticals Market Challenges
- 15.4 Diagnostic Radiopharmaceuticals Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
Summary:
Get latest Market Research Reports on Diagnostic Radiopharmaceuticals . Industry analysis & Market Report on Diagnostic Radiopharmaceuticals is a syndicated market report, published as Global Diagnostic Radiopharmaceuticals Sales Market Report 2021. It is complete Research Study and Industry Analysis of Diagnostic Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
